Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program.

Area of Science:

• Developmental Biology
• Hematopoiesis
• Stem Cell Biology

Background:

• Studying hematopoiesis (blood cell formation) in vitro is crucial for understanding blood disorders.
• Existing methods for generating hematopoietic cells in vitro have limitations.
• Mouse embryonic fibroblasts (MEFs) offer a potential cell source for reprogramming.

Purpose of the Study:

• To identify a minimal set of transcription factors (TFs) capable of inducing a hemogenic program in MEFs.
• To establish an in vitro model that recapitulates developmental hematopoiesis.
• To provide a platform for studying hematopoiesis mechanisms and generating patient-specific hematopoietic stem cells (HSCs).

Main Methods:

• Utilized a reporter system in MEFs from transgenic mice (CD34-tTA/TetO-H2BGFP) to track cell fate.
• Screened 18 candidate TFs for their ability to induce GFP expression, indicating hematopoietic or endothelial fate.
• Employed combinatorial elimination to determine the minimal TF set for optimal induction.

Main Results:

• Identified Gata2, Gfi1b, and cFos as necessary TFs for hemogenic induction.
• Found that adding Etv6 to the TF set optimized the induction percentage.
• Gene expression analyses indicated an endothelial to hematopoietic transition (EHT) during reprogramming.

Conclusions:

• Successfully reprogrammed MEFs into hematopoietic cells using a defined set of TFs, mimicking developmental hematopoiesis.
• This 'in vitro' model facilitates the study of hematopoiesis and its underlying mechanisms.
• The methodology holds promise for generating patient-specific HSCs for therapeutic applications in hematologic diseases.